Glaxosmi. Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE159A01016
  • NSEID: GLAXO
  • BSEID: 500660
INR
2,484.70
5.75 (0.23%)
BSENSE

May 08

BSE+NSE Vol: 1.19 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryGlaxosmi. Pharma VS Pharmaceuticals & Biotechnology
 
1D
0.23%
-0.66%
1W
6.38%
0.54%
1M
5.52%
-0.3%
YTD
0.56%
-9.26%
1Y
-9.09%
-3.74%
3Y
97%
25.2%
5Y
69.35%
57.15%
10Y
38.68%
206.51%
  • Stock Absolute Returns
  • India SENSEXAbsolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-0.05%
0%
-0.05%
6 Months
-4.09%
0%
-4.09%
1 Year
-9.09%
0%
-9.09%
2 Years
23.44%
1.88%
25.32%
3 Years
97.0%
5.83%
102.83%
4 Years
62.86%
8.95%
71.81%
5 Years
69.35%
11.01%
80.36%

Latest dividend: 12 per share ex-dividend date: Nov-07-2024

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Inconsistent Performance

Glaxosmithkline Pharmaceuticals Ltd has not been a consistent performer in the last 1 year and longer periods

2
Quartile
quartile-2
QTD
8.82%
3
Quartile
quartile-3
Dec-Mar
-7.59%
4
Quartile
quartile-4
Sep-Dec
-6.99%
4
Quartile
quartile-4
1Y
-9.64%
1
Quartile
quartile-1
2025
9.98%
3
Quartile
quartile-3
2024
18.41%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry stock-summary
Inconsistent Performance

Glaxosmithkline Pharmaceuticals Ltd has not been a consistent performer in the last 1 year and longer periods

4
Quartile
quartile-4
QTD
8.82%
2
Quartile
quartile-2
Dec-Mar
-7.59%
3
Quartile
quartile-3
Sep-Dec
-6.99%
3
Quartile
quartile-3
1Y
-9.64%
1
Quartile
quartile-1
2025
9.98%
3
Quartile
quartile-3
2024
18.41%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap stock-summary
Inconsistent Performance

Glaxosmithkline Pharmaceuticals Ltd has not been a consistent performer in the last 1 year and longer periods

4
Quartile
quartile-4
QTD
8.82%
2
Quartile
quartile-2
Dec-Mar
-7.59%
4
Quartile
quartile-4
Sep-Dec
-6.99%
4
Quartile
quartile-4
1Y
-9.64%
2
Quartile
quartile-2
2025
9.98%
3
Quartile
quartile-3
2024
18.41%
Click on any of the quartiles for detailed breakdown
stock-summaryRisk Adjusted Returns v/s India SENSEX
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available